219
Participants
Start Date
September 4, 2013
Primary Completion Date
February 25, 2015
Study Completion Date
November 17, 2016
Apremilast 30 mg
30mg of Apremilast will be orally administered twice daily for 104 weeks
Placebo
Identically appearing Placebo tablets will be orally administered twice daily for up to 24 weeks
Qualiclinic kft, Budapest
Middlemore Clinical Trials, Manukau
Royal Prince Alfred Hospital, Camperdown
Westmead Cancer Care Center, Westmead, NSW
Optimus Clinical Research Pty. Ltd, Kogarah
Eastern Health Clinical School, Box Hill
Waikato hospital, Hamilton
Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Debrecen
Coastal Joint Care, Maroochydore
MAV Korhaz es Rendelointezet Szolnok, Szolnok
Colin Bayliss Research and Teaching Unit, Victoria Park
Menzies Centre for Population Health Research, Hobart
Veszprém Megyei Önkormányzat Csolnoky Ferenc Kórház-Rendelöintézet, Veszprém
Timaru Hospital, Timaru
Hospital Universitario a Coruna, A Coruña
Hospital Clinico Universitario de Santiago, Santiago de Compostela
Altoona Center for Clinical Research, Duncansville
Mountain State Clinical Research, Clarksburg
Physicians East, Greenville
Hospital Universitario La Paz, Madrid
Hospital General Carlos Haya, Málaga
Palmetto Medical Research, Hialeah
Bay Area Arthritis and Osteoporosis, Brandon
Health Point Medical Group, Brandon
Jeffrey Alper MD Research, Naples
Suncoast Clinical Research, New Port Richey
Achieve Clinical Research LLC, Birmingham
Ramesh C Gupta MD, Memphis
West Tennessee Research Institute, Jackson
Hospital Universitario de Canarias, San Cristóbal de La Laguna
Hospital de Basurto-Osakidetza, Bilbao
Advanced Rheumatology, Lansing
Clinical Research Centre Ltd, Tartu
Research West Incorporated, Kalispell
Rockford Orthopedic Associates, LLC, Rockford
Heartland Clinical Research, Inc., Omaha
Baylor Research Institute, Dallas
Houston Medical Research, Houston
Austin Regional Clinic, Austin
Arthritis and Osteoporosis Associates LLP, Lubbock
Coeur D'Alene Arthritis Clinic, Coeur d'Alene
University of Utah, Salt Lake City
Desert Medical Advances, Palm Desert
Yaroslavl Regional Clinical Hospital, Yaroslavl
Departmental Hospital at Smolensk Station RZhD JSC, Smolensk
Emergency County Clinical Hospital, Cluj-Napoca
Research Medical Complex Vashe Zdorovie, Kazan'
Penza Regional Clinical Hospital n.a. N.N. Burdenko, Penza
SC Covamed SRL, Sfantu Gheorghe, Covasna
Sf Apostol Andrei Emergency Clinical County Hospital, Galati
University of South Florida, Tampa
Piedmont Medical Research Associates Inc, Winston-Salem
Manna Research, Vancouver
Manitoba Clinic, Winnipeg
Karma Clinical Trials, St. John's
Nexus Clinical Research, St. John's
MAC Research Incorporated, Hamilton
Arthur Karasik Private Practice, Toronto
Manna Research, Toronto
Jude Rodrigues Private Practice, Windsor
CHUL du CHU de Quebec, Québec
Revmatologicky ustav, Prague
Revmatologicka Ambulance, Prague
Revmatologicka Ambulance, Sokolov
PV - MEDICAL, s.r.o., Zlín
Innomedica Medical and Research Centre, Tallinn
East Tallinn Central Hospital, Tallinn
Sf. Maria Clinical Hospital, Bucharest
Hospital Vall d'Hebron, Barcelona
Hospital Universitari de Bellvitge, Barcelona, Hospitalet de Llobregat
Corporacion Sanitaria Parc Tauli, Sabadell
Lead Sponsor
Amgen
INDUSTRY